Mission

The principal purpose of the Fibrolamellar Cancer Foundation (FCF) is to encourage, drive and fund research that will substantially improve outcomes for patients with fibrolamellar carcinoma (FLC), a rare form of liver cancer that primarily occurs in adolescents and young adults who have no history of liver disease. Given the urgent need for clinically-proven therapies for this disease, our mission is three-fold: (1) find a cure and effective treatment options for FLC; (2) connect and support the fibrolamellar community; and (3) raise awareness of this disease.